Use of a novel microbiome modulator improves anticancer immunity in a murine model of malignant pleural mesothelioma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Use of a novel microbiome modulator improves anticancer immunity in a murine model of malignant pleural mesothelioma

Published:2024-04 Issue: Volume:18 Page:324-344
ISSN:2666-2736
Container-title:JTCVS Open
language:en
Short-container-title:JTCVS Open

Author:

Gattlen Christophe,Frank Kirby R.,Marie Damien N.,Trompette Aurélien,Chriqui Louis-Emmanuel,Hao Yameng,Abdelnour Etienne,Gonzalez Michel,Krueger Thorsten,Dyson Paul J.,Siankevich Sviatlana,von Garnier Christophe,Ubags Niki D.J.,Cavin Sabrina,Perentes Jean Y.

Funder

China Scholarship Council

Publisher

Elsevier BV

Reference26 articles.

1. Improving outcomes in malignant pleural mesothelioma in an integrated health care system;Ossowski;J Thorac Dis,2022

2. First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial;Baas;Lancet,2021

3. Mechanisms of primary and secondary resistance to immune checkpoint inhibitors in cancer;Seto;Med Sci (Basel),2019

4. A defined commensal consortium elicits CD8 T cells and anti-cancer immunity;Tanoue;Nature,2019

5. Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients;Gopalakrishnan;Science,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP